125 related articles for article (PubMed ID: 22778955)
21. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
22. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
[TBL] [Abstract][Full Text] [Related]
23. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
Mukherjee R; Mingoia JT; Bruce JA; Austin JS; Stroud RE; Escobar GP; McClister DM; Allen CM; Alfonso-Jaume MA; Fini ME; Lovett DH; Spinale FG
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2216-28. PubMed ID: 16766634
[TBL] [Abstract][Full Text] [Related]
24. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
25. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
26. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
27. The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.
Nagel F; Santer D; Stojkovic S; Kaun C; Schaefer AK; Krššák M; Abraham D; Bencsik P; Ferdinandy P; Kenyeres E; Szabados T; Wojta J; Trescher K; Kiss A; Podesser BK
Exp Gerontol; 2019 May; 119():193-202. PubMed ID: 30763602
[TBL] [Abstract][Full Text] [Related]
28. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.
Kandalam V; Basu R; Abraham T; Wang X; Awad A; Wang W; Lopaschuk GD; Maeda N; Oudit GY; Kassiri Z
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1012-23. PubMed ID: 20675565
[TBL] [Abstract][Full Text] [Related]
29. [Effects of angiotensin II receptor antagonism on matrix metalloproteinases and fibronectin in rats with experimental myocardial infarction].
Zhang X; Yang YJ; Zhu WL; Huang Y; Zhu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1029-34. PubMed ID: 17288771
[TBL] [Abstract][Full Text] [Related]
30. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
[TBL] [Abstract][Full Text] [Related]
31. CD8
Ilatovskaya DV; Pitts C; Clayton J; Domondon M; Troncoso M; Pippin S; DeLeon-Pennell KY
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H581-H596. PubMed ID: 31322426
[TBL] [Abstract][Full Text] [Related]
32. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
[TBL] [Abstract][Full Text] [Related]
33. Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.
Yarbrough WM; Mukherjee R; Stroud RE; Meyer EC; Escobar GP; Sample JA; Hendrick JW; Mingoia JT; Spinale FG
J Cardiovasc Pharmacol; 2010 Apr; 55(4):408-16. PubMed ID: 20147844
[TBL] [Abstract][Full Text] [Related]
34. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
35. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
36. CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction.
Zamilpa R; Kanakia R; Cigarroa J; Dai Q; Escobar GP; Martinez H; Jimenez F; Ahuja SS; Lindsey ML
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1418-26. PubMed ID: 21297029
[TBL] [Abstract][Full Text] [Related]
37. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Bradham WS; Gunasinghe H; Holder JR; Multani M; Killip D; Anderson M; Meyer D; Spencer WH; Torre-Amione G; Spinale FG
J Am Coll Cardiol; 2002 Dec; 40(12):2165-73. PubMed ID: 12505230
[TBL] [Abstract][Full Text] [Related]
38. Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
[TBL] [Abstract][Full Text] [Related]
39. S100B: role in cardiac remodeling and function following myocardial infarction in diabetes.
Mohammadzadeh F; Desjardins JF; Tsoporis JN; Proteau G; Leong-Poi H; Parker TG
Life Sci; 2013 Mar; 92(11):639-47. PubMed ID: 23000886
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction.
Daniel LL; Daniels CR; Harirforoosh S; Foster CR; Singh M; Singh K
J Am Heart Assoc; 2014 Dec; 3(6):e001286. PubMed ID: 25520329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
